Lisata Therapeutics's market cap is currently $21.63M. The company's EPS TTM is $-0.54; its P/E ratio is ―; Lisata Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
